Pityriasis Lichenoides et Varioliformis Acuta: Remission with Hypopigmentation.

Authors:
Henning Hamm
Henning Hamm
University of Würzburg

J Pediatr 2016 Sep 11;176:211-211.e1. Epub 2016 Jun 11.

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2016.05.057DOI Listing
September 2016
5 Reads

Publication Analysis

Top Keywords

varioliformis acuta
4
lichenoides varioliformis
4
remission hypopigmentation
4
acuta remission
4
pityriasis lichenoides
4
hypopigmentation
1
acuta
1
varioliformis
1
pityriasis
1
remission
1

Similar Publications

Pityriasis lichenoides et varioliformis acuta in skin of color: new observations by dermoscopy.

Dermatol Pract Concept 2017 Jan 31;7(1):27-34. Epub 2017 Jan 31.

Department of Dermatology, S. Nijalingappa Medical College, Bagalkot, Karnataka, India.

Background: Pityriasis lichenoides is an uncommon skin disease that presents in three different forms: pityriasis lichenoides et varioliformis acuta (PLEVA), pityriasis lichenoides chronica (PLC) and febrile ulceronecrotic-Mucha-Habermann disease. These represent a spectrum of a disease. PLEVA presents as skin eruption of multiple, small, red papules that develop into polymorphic lesions with periods of varying remissions, as well as possible sequels of hyper/hypopigmentation and varicella-like scars. Read More

View Article
January 2017

Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica.

J Am Acad Dermatol 2002 Sep;47(3):410-4

Department of Dermatology, Azienda Spedali Civili di Brescia, Brescia, Italy.

Background: Ultraviolet A1 (340-400 nm) was found to be effective in the treatment of cutaneous T-cell-mediated diseases.

Objective: The purpose of the present study was to assess the efficacy of UVA1 phototherapy for pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC).

Methods: Eight patients (3 with PLEVA and 5 with PLC) received 60 J/cm(2) UVA1 daily until remission. Read More

View Article
September 2002

The relevance of recognizing clinical and morphologic features of pityriasis lichenoides: clinicopathological study of 29 cases.

Dermatol Pract Concept 2013 31;3(4):7-10. Epub 2013 Oct 31.

Division of Pediatrics, ITPAC-Porto Nacional, Tocantins, Brazil.

Background: Pityriasis lichenoides (PL) is a lymphoproliferative disease of unknown origin; its diagnosis is based on clinical characteristics and confirmed by histology.

Objectives: To describe clinical and histological features of PL in 29 pediatric patients.

Materials And Methods: Retrospective descriptive study of children (patients less than 15 years old) diagnosed with PL between 1986 and 2010 at a Reference Service in Pediatric Dermatology from South Brazil. Read More

View Article
November 2013

Pityriasis lichenoides: Long-term follow-up study.

Pediatr Dermatol 2018 Mar 9;35(2):213-219. Epub 2018 Jan 9.

Department of Dermatology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Background/objectives: Pityriasis lichenoides is an uncommon papulosquamous disorder of unknown etiology. The objective of this study was to review the clinical features and treatment responses of individuals with pityriasis lichenoides seen at a tertiary referral center.

Methods: Seventy-five patients diagnosed with pityriasis lichenoides between 1997 and 2013 were reviewed, and 46 had long-term follow-up via telephone interviews. Read More

View Article
March 2018